Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (17 ops.)
Latest filing published 07 Aug 2026 for Acadia Pharmaceuticals INC, €90k. Read the official filing
Filing timeline
BuySaleMark C. Schneyer
Insider track record
Disclosed buys
0
Disclosed sells
17
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Mark C. Schneyer: trading record in brief
Mark C. Schneyer is a declared insider of Acadia Pharmaceuticals Inc (finance chief), with filings sourced from SEC (Form 4). Between 23 February 2022 and 6 August 2026, the trades on record add up to 45 filings.
On the market, this insider has only sold: 17 sales, €2.0M in total. The rest of the record consists of 4 share grants and 24 option exercises. 2026 to date brings no purchases and 5 sales.
Most recently, on 7 August 2026, the filings show an option exercise worth €90k in Acadia Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Mark C. Schneyer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations45 total
5,849 shares@ US$17.840.0022% mcap3.7% of flowCommon StockSEC:0001899977-26-000008:0
5,849 shares@ US$29.00290.0036% mcap6.0% of flowCommon StockSEC:0001899977-26-000008:1
9,292 shares@ US$29.33750.0058% mcap9.6% of flowCommon StockSEC:0001899977-26-000008:4
14,292 shares@ US$17.840.0055% mcap9.0% of flowCommon StockSEC:0001899977-26-000008:2
5,000 shares@ US$29.000.0031% mcap5.1% of flowCommon StockSEC:0001899977-26-000008:3
3,506 shares@ US$21.790.0014% mcap4.3% of flowCommon StockSEC:0001899977-26-000007:1
6,815 sharesCommon StockSEC:0001899977-26-000007:0
2,709 shares@ US$22.200.0011% mcap3.4% of flowCommon StockSEC:0001899977-26-000005:1
5,276 sharesCommon StockSEC:0001899977-26-000005:0
8,138 sharesCommon StockSEC:0001899977-26-000003:0
9,913 sharesCommon StockSEC:0001899977-25-000006:0
3,498 shares@ US$23.654.7% of flowCommon StockSEC:0001899977-25-000004:1
6,815 shares0Common StockSEC:0001899977-25-000004:0
22,000 shares@ US$25.182931.6% of flowCommon StockSEC:0001415889-25-022359:0
2,000 shares@ US$25.003.0% of flowCommon StockSEC:0001415889-25-013741:0
6,815 sharesCommon StockSEC:0001415889-25-011872:0
2,708 shares@ US$14.822.4% of flowCommon StockSEC:0001415889-25-010424:1
5,275 sharesCommon StockSEC:0001415889-25-010424:0
6,178 sharesCommon StockSEC:0001415889-25-009074:0
773 shares@ US$19.961.0% of flowCommon StockSEC:0001415889-25-005574:1
1,353 sharesCommon StockSEC:0001415889-25-005574:0
10,259 shares@ US$16.8110.8% of flowCommon StockSEC:0001415889-24-027292:2
9,913 sharesCommon StockSEC:0001415889-24-027292:1
9,913 sharesCommon StockSEC:0001415889-24-027292:0
5,275 shares0Common StockSEC:0001415889-24-021731:0
25 of 45 declarations
